The 20 Best COVID-19 Doctors Near Me in Rosedale, MD

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis. Dr. Werbel is board certified in American Board Of Internal Medicine.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Embolectomy, and Lung Transplant. Dr. Brodie is board certified in American Board Of Internal Medicine.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, Cerebral Hypoxia, and Acute Respiratory Distress Syndrome (ARDS). Dr. Hager is board certified in American Board Of Internal Medicine.

Thomas Cudjoe is a primary care provider, practicing in Geriatrics in Baltimore, Maryland. Dr. Cudjoe is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), and Dementia. Dr. Cudjoe is board certified in American Board Of Internal Medicine.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Arteriovenous Fistula, Chronic Obstructive Pulmonary Disease (COPD), COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Galiatsatos is board certified in American Board Of Internal Medicine.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and COVID-19. Dr. Kirk is board certified in American Board Of Internal Medicine.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gebo is board certified in American Board Of Internal Medicine.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Meningitis, and Tissue Biopsy.

Dr. Bailey received his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine through the Medical Scientist Training Program and completed medical residency at the Massachusetts General Hospital. He subsequently completed fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine before transitioning to a faculty position. His primary clinical interests are management and treatment of HIV and viral hepatitis, including hepatitis c virus. His research interests include the study of human B cells and neutralizing antibody responses against hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, and respiratory syncytial virus (RSV), with the goal of developing improved vaccines against these viruses. Dr. Bailey is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Hepatitis C, COVID-19, Hepatitis, and Long Haul COVID. Dr. Bailey is board certified in American Board Of Internal Medicine.

Dr. Nate Permpalung is an Associate Professor of Medicine and serves as the Director of Mycology Research in the Division of Infectious Diseases and Associate Director for Clinical Trials of Transplant Research Center at Johns Hopkins University School of Medicine. In his capacity as a Transplant Infectious Disease physician at Johns Hopkins Hospital, he provides specialized care to immunocompromised patients, including those who have undergone solid organ transplants and those undergoing cancer treatment. His research focuses are respiratory viral infections, invasive fungal infections, fungal-viral interactions, fungal diagnostics, and human pythiosis. Nationally, Dr. Permpalung has served on the panel for the IDSA Aspergillosis Guidelines development and has held editorial positions as Associate Editor for Medical Mycology and as an Editorial Board Member for the Journal of Heart and Lung Transplantation Open. Dr. Permpalung is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, COVID-19, Febrile Neutropenia, and Respiratory Syncytial Virus (RSV) Infection. Dr. Permpalung is board certified in American Board Of Internal Medicine.

Sriram Padmanabhan is a Nuclear Medicine provider practicing medicine in Baltimore, Maryland. Dr. Padmanabhan is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Atrial Fibrillation, Atherosclerosis, and Angina.

Morgan Katz, M.D., MHS, is an Associate Professor of medicine at The Johns Hopkins University School of Medicine and the Director of Antimicrobial Stewardship at Johns Hopkins Bayview Hospital. Her area of clinical expertise is infectious diseases. Her research interests lie in infection control and antibiotic stewardship in long-term care facilities. She has focused her career on designing feasible interventions to reduce antimicrobial resistance and transmission of infection in the long-term care setting. She served as a member of the White House Nursing Home Commission to guide the Centers for Medicare and Medicaid in their response to Coronavirus in long-term care facilities, and has published widely on infection prevention and antibiotic stewardship in long-term care. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Lemierre Syndrome, Severe Acute Respiratory Syndrome (SARS), COVID-19, Osteomyelitis, and Thrombectomy.

Dr. Monica Mukherjee is an adult cardiologist and an Associate Professor of Medicine at the Johns Hopkins University Division of Cardiology and specializes in advanced cardiac imaging. She serves as Medical Director of the Echocardiography Lab at Johns Hopkins Bayview Medical Center, and as Associate Director of the Johns Hopkins Echocardiography program across the institution. Dr. Mukherjee graduated Summa Cum Laude with dual Bachelors of Science in Psychology and Behavioral Neurosciences from the University of Florida. She received her Doctorate in Medicine from the George Washington University in Washington, DC, and internal medicine residency at Drexel University, before returning to George Washington to complete her fellowship in cardiovascular disease. She has a MPH from the Johns Hopkins Bloomberg School of Public Health with a special concentration in Epidemiological and Biostatistical Methods for Public Health and Clinical Research. Dr. Mukherjee has an accomplished academic career with multiple research awards focused on right ventricular remodeling in heart failure, pulmonary hypertension, and scleroderma. She was the recipient of the 2020 Johns Hopkins University Clinician Scientist Award and also has been funded by the National Institutes of Health, the Scleroderma Foundation, and the CHEST Foundation. She was awarded the Top 25 Young Investigators Award from the American Society of Echocardiography in 2016. Dr. Mukherjee is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Heart Attack, Systemic Sclerosis (SSc), Tissue Biopsy, and Pacemaker Implantation. Dr. Mukherjee is board certified in American Board Of Internal Medicine.

Dr. Sean X. Leng is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include geriatric medicine. Dr. Leng earned his M.D. from Jiangxi Medical College and his Ph.D. from Texas A&M University Health Sciences Center. He completed his residency at Mount Sinai St. Luke's - Roosevelt Hospitals and performed a fellowship in geriatric medicine and gerontology at Johns Hopkins. His research interests include international collaborative development of geriatrics and aging research programs. In 2006 Dr. Leng received the Paul Beeson Career Development Award in Aging Research, one of the most prestigious in the field of geriatric research. Dr. Leng is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Cytomegalovirus Infection, Flu, Cytomegalic Inclusion Disease, HIV/AIDS, and Thyroidectomy. Dr. Leng is board certified in American Board Of Internal Medicine.

Dr. Karaba is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. She is an infectious diseases physician and the Associate Director of the Antimicrobial Stewardship Program and an Associate Hospital Epidemiologist at Johns Hopkins Bayview Medical Center. Dr. Karaba’s research interests include the epidemiology and treatment multidrug-resistant bacterial infections and the prevention of hospital-acquired infections. Dr. Karaba is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her clinical expertise encompasses Sepsis, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Pneumonia. Dr. Karaba is board certified in American Board Of Internal Medicine.

Khalil Ghanem's, M.D., Ph.D., research interests include sexually transmitted infections and the vaginal microbiome. In 2008, he received his Ph.D. degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Ghanem is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Neurosyphilis, Syphilis, Gonorrhea, and Chlamydia. Dr. Ghanem is board certified in American Board Of Internal Medicine.

Dr. Ann Marie Parker is an instructor of medicine at the Johns Hopkins University School of Medicine. Her clinical focus is in pulmonary and critical care medicine, with a special interest in critically ill oncology patients as well as delirium and rehabilitation in the ICU. She earned her M.D. at the University of Maryland School of Medicine. She completed her residency at the University of Maryland Medical Center and a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Parker joined the Johns Hopkins faculty in 2016. Dr. Parker is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Long Haul COVID, Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), COVID-19, and Pancreaticoduodenectomy. Dr. Parker is board certified in American Board Of Internal Medicine.

Dr. Sarath Raju is an instructor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include obstructive lung diseases (asthma, chronic obstructive pulmonary disease), chronic lung disease in persons living with HIV, and critical care medicine. Dr. Raju earned his M.D. from Rush Medical College. He completed his residency at Johns Hopkins, where he also performed a fellowship in pulmonary and critical care medicine. He previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program at Johns Hopkins. Dr. Raju joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct research investigating the intersection of HIV, environmental exposures, and lung health. Dr. Raju is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Bronchogenic Cyst, Lung Metastases, Bronchitis, and Endoscopy. Dr. Raju is board certified in American Board Of Internal Medicine.

Dr. Noreen Hynes has over 35 years of medical and public health experience in both international and domestic settings. Her career has encompassed basic and applied research, epidemiology, public health, clinical medicine, and the regulatory aspects of medical countermeasures for emerging and infectious diseases and high-consequence pathogens. Dr. Hynes has been affiliated with The Johns Hopkins Medical Institutions and the Schools of Medicine and Public Health University since 1997. She is currently an Associate Professor of Medicine (part-time) in the School of Medicine, Division of Infectious Diseases, and is jointly appointed in the School of Public Health in the Department of International Health. Since 2009, Dr. Hynes has served as the director of the Geographic Medicine Center in the Division of Infectious Diseases in the Johns Hopkins School of Medicine, as the Medical Director of the Johns Hopkins Tropical & Travel Medicine Service, and as the Baltimore Site Director for the CDC-sponsored GeoSentinel Surveillance System. Dr. Hynes serves as the Director of Research and the Associate Medical Director of the Johns Hopkins Hospital BioContainment Unit. She also serves as the co-director of the Infectious Disease concentration in the Johns Hopkins Master of Public Health degree program. Dr. Hynes' research interests focus on infectious diseases at the clinical-public health interface in resource-constrained settings in both tropical and temperate regions. Her research focuses on tropical diseases, including those that or zoonoses or high-consequence pathogens. Her research focuses on these pathogens including examining deliberate and naturally-occurring exposures/outcomes, the epidemiology and control of emerging infectious diseases, and collaboration on vaccine clinical trials conducted by the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health. Dr. Hynes is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her clinical expertise encompasses Viral Hemorrhagic Fever, Ebola Virus Disease, Dengue Fever, and COVID-19. Dr. Hynes is board certified in American Board Of Internal Medicine.

Dr. Bruce Leff is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the department of health policy and management in the Johns Hopkins Bloomberg School of Public Health and the Department of Community and Public Health in the Johns Hopkins School of Nursing. Dr. Leff is an internationally recognized leader and researcher in the development, evaluation and dissemination of novel models of care for older adults, including the Hospital at Home, Guided Care, geriatric service line models and medical house call practices. In addition, his research interests extend to issues related to multi-morbidity, performance measurement and case-mix issues. He has a strong interest in health policy issues, is a past Health and Aging Policy Fellow of the American Political Science Association, and has served on multiple technical expert panels for the National Quality Forum, NCQA, and Centers for Medicare and Medicaid Services. An award-winning teacher and mentor, Dr. Leff directed the basic Medicine Clerkship in the School of Medicine until 2021. He is a past-president of the American Academy of Home Care Physicians, past-member of the Board of Regents of the American College of Physicians. He is also past- Chair of the Council of the American Board of Internal Medicine (ABIM), as well as the past-Chair of the ABIM Geriatric Medicine Board. He currently serves on the Board of Trustees of the ABIM Foundation. Dr. Leff received his B.A. from the University of Pennsylvania in 1983 and his M.D. from New York University in 1987. After residency and fellowship training at Johns Hopkins, he served as a medical officer in the US Army in Seoul, Korea, before joining the faculty in the Department of Medicine in 1994. Dr. Leff is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Dementia, Severe Acute Respiratory Syndrome (SARS), Hypertension, and COVID-19. Dr. Leff is board certified in American Board Of Internal Medicine.